UBS Group AG's Form 4/A amendment
AmendedENDRA Life Sciences Inc. (NDRA) · filed Sep 5, 2024
- Accession no.
- 0001610520-24-000153
- Filed
- Sep 5, 2024
- Trade date
- Aug 27, 2024
- Filing delay
- 9 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Aug 29, 2024
This filing lists 1 non-derivative transaction. It was filed 9 days after the trade.
This amendment replaces 0001610520-24-000151 (filed Aug 29, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| UBS Group AGCIK 0001610520 | Other: Market maker/broker-dealer |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2024 | Common Stock | PPurchaseAcquired | 0 | $0.00 | $0 | 146,012 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This Statement is filed jointly by UBS Group AG for the benefit and on behalf of UBS Securities LLC and UBS Financial Services Inc., a wholly owned subsidiary of UBS Group.
- F2
This Form 4 Amendment is being filed to correct and replace the original Form 4 filed on August 29, 2024. Subsequent to the date of first filing, the Reporting Person confirmed directly with the Issuer that, due to certain warrant exercises effected on August 27, 2024, the total outstanding common shares issued by ENDRA Life Sciences as of August 27, 2024 was 16,932,593 shares. When taking the revised share count into consideration, the Reporting Person determined it never beneficially owned more than 10% of ENDRA shares. Therefore the Form 4 previously filed by the Reporting Person was erroneous and unnecessary